Maryland Capital Advisors’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$254K Buy
+10,504
New +$254K 0.08% 77
2025
Q4
$302K Sell
12,429
-179
-1% -$4.35K 0.1% 68
2025
Q3
$307K Sell
12,608
-1,396
-10% -$33.9K 0.11% 65
2025
Q2
$340K Hold
14,004
0.13% 63
2025
Q1
$339K Buy
14,004
+7,893
+129% +$190K 0.15% 59
2024
Q4
$146K Buy
6,111
+2,336
+62% +$56.2K 0.07% 83
2024
Q3
$92K Sell
3,775
-176
-4% -$4.24K 0.04% 98
2024
Q2
$93.8K Sell
3,951
-48
-1% -$1.14K 0.05% 96
2024
Q1
$95.2K Buy
+3,999
New +$95.2K 0.06% 90

Other funds holding IBDS

Maryland Capital Advisors's IBDS Position: Q2 2026 in Review

Maryland Capital Advisors opened a new position in iShares iBonds Dec 2027 Term Corporate ETF (IBDS) in Q2 2026: 10,504 shares worth $254K. The stake represents 0.08% of the portfolio and ranks #77 among its holdings. This is a return to the name: Maryland Capital Advisors previously reported a position in IBDS as recently as Q4 2025.

Maryland Capital Advisors first reported a position in IBDS in Q1 2024 and has held it in 9 quarters since. The position peaked at $340K in Q2 2025. 280 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Maryland Capital Advisors held 10,504 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $254K as of Q2 2026.
  • iShares iBonds Dec 2027 Term Corporate ETF was a new Maryland Capital Advisors position in Q2 2026.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.08% of Maryland Capital Advisors's portfolio in Q2 2026, its #77 holding.
  • Maryland Capital Advisors first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q1 2024 and has held it in 9 quarters since.
  • Maryland Capital Advisors's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $340K in Q2 2025.
  • 280 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Maryland Capital Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.